Le Lézard
Classified in: Health, Business
Subject: AWD

Caravan Health Selected by CMS as Awardee of the Network of Quality Improvement and Innovation Contractor


KANSAS CITY, Mo., June 13, 2019 /PRNewswire-PRWeb/ -- The Centers for Medicare & Medicaid Services selected Caravan Health as a Prime awardee of the Network of Quality Improvement and Innovation Contractor. This designation will allow NQIICs to bid on Task Orders over the next five years. As a Prime NQIIC awardee partnering with other Quality Improvement contractors under the new CMS Indefinite Delivery/Indefinite Quantity (IDIQ) contract mechanism to support quality improvement efforts, each NQIIC may serve as:

As a NQIIC awardee, Caravan Health has demonstrated healthcare quality improvement expertise. Services supported by some of the NQIIC awardees may include:

About Caravan Health
Caravan Health is the national leader of successful accountable care and population health programs for community health systems. Caravan Health works with more than 250 health systems, 14,000 providers and more than 1,000,000 patient lives to drive quality, financial benefits and strong physician relationships in accountable care organizations.?For more information visit http://www.CaravanHealth.com.

 

SOURCE Caravan Health


These press releases may also interest you

at 21:41
Farm Boy is recalling Farm Boy brand cheese balls from the marketplace due to possible Listeria monocytogenes contamination. Consumers should not consume the recalled products described below. The following products have been sold in Ontario....

at 20:40
AVITA Medical , a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today the appointment of David McIntyre as Chief Financial Officer (CFO) effective...

at 19:30
3SBio Inc. ("3SBio") (HKEX:1530) and Verseau Therapeutics, Inc. ("Verseau") today announced the selection of VTX-0811, a monoclonal antibody targeting PSGL-1, as the first licensed program under their partnership agreement focused on the development...

at 19:00
WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries, today announced its Lab Testing Division (LTD) has expanded the Suzhou safety assessment...

at 16:35
Personalis, Inc. , a leader in advanced genomics for cancer, today announced that the company will participate in the AACR Tumor Immunology and Immunotherapy conference at the Boston Marriott Copley Place in Boston, MA, November 17-20, including...

at 16:05
Karuna Therapeutics, Inc. , a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today...



News published on 13 june 2019 at 18:00 and distributed by: